FDA Inspection 942326 — Chen Shwezin, Inc. dba Park Compounding Pharmacy

Chen Shwezin, Inc. dba Park Compounding Pharmacy — FEI 3005256616

The FDA completed an inspection of Chen Shwezin, Inc. dba Park Compounding Pharmacy on September 11, 2015 in Westlake Village, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 10 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 11, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Westlake Village, CA (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
119421 CFR 211.42(c)Defined areas of adequate size for operations
142121 CFR 211.42(c)(10)Aseptic Processing Area
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
143521 CFR 211.42(c)(10)(v)Cleaning System
143621 CFR 211.42(c)(10)(vi)Equipment to control conditions
145121 CFR 211.113(b)Procedures for sterile drug products
176721 CFR 211.137(a)Expiration date lacking
186821 CFR 211.94(b)Protection from external factors
193221 CFR 211.167(a)Sterility/pyrogen-free testing